Kathleen Murphy

OverviewAI-generated summary

Kathleen Murphy's research program focuses on the pathogenesis of oncogenic gammaherpesviruses, including Kaposi's sarcoma-associated herpesvirus (KSHV). She has served as Principal Investigator on multiple NIH-funded grants totaling over $1.2 million, investigating mechanisms of gammaherpesvirus-driven genomic instability in B cells, KSHV LANA functions in viral pathogenesis and immune evasion, and the role of lytic viral genes in oncogenic gammaherpesvirus pathogenesis. Her work also examines how periodontal bacteria enhance oral KSHV pathogenesis and Kaposi's sarcoma development in HIV-positive patients, for which she is a Co-PI on an NIH grant of over $300,000.

Murphy's recent publications indicate a broadening of her research interests to include kidney disease and maternal-fetal health. She has published on the National Kidney Foundation's Patient Network for individuals with kidney disease, treatment patterns for complement 3 glomerulopathy (C3G), and the characteristics and progression of C3G in a multi-center assessment. Additionally, her work addresses respiratory distress in preterm neonates and the association between early antibiotic exposure and preschool growth trajectories. Her scholarship metrics include an h-index of 12, with 43 total publications and over 1,000 citations.

Metrics

• h-index: 12
• Publications: 43
• Citations: 1,068